275 related articles for article (PubMed ID: 29886786)
21. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.
Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L
J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693
[TBL] [Abstract][Full Text] [Related]
22. Apatinib strengthens the anti-tumor effect of cisplatin in thyroid carcinoma through downregulating VEGFR2.
Hu Y; Zhou N; Wang R
J BUON; 2021; 26(2):613-619. PubMed ID: 34077013
[TBL] [Abstract][Full Text] [Related]
23. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
24. Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter.
Zhang Q; Song Y; Cheng X; Xu Z; Matthew OA; Wang J; Sun Z; Zhang X
Anticancer Res; 2019 Oct; 39(10):5461-5471. PubMed ID: 31570440
[TBL] [Abstract][Full Text] [Related]
25. Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma.
Zhao Y; Zhang J; Tian Y; Xue C; Hu Z; Zhang L
Drug Des Devel Ther; 2015; 9():4897-907. PubMed ID: 26345996
[TBL] [Abstract][Full Text] [Related]
26. Apatinib for patients with advanced or recurrent cervical cancer: study protocol for an open-label randomized controlled trial.
Zhou JG; Zhou NJ; Zhang Q; Feng YY; Zhou H
Trials; 2018 Sep; 19(1):500. PubMed ID: 30223869
[TBL] [Abstract][Full Text] [Related]
27. Apatinib inhibits glioma cell malignancy in patient-derived orthotopic xenograft mouse model by targeting thrombospondin 1/myosin heavy chain 9 axis.
Yao H; Liu J; Zhang C; Shao Y; Li X; Yu Z; Huang Y
Cell Death Dis; 2021 Oct; 12(10):927. PubMed ID: 34635636
[TBL] [Abstract][Full Text] [Related]
28. Tubeimoside I induces accumulation of impaired autophagolysosome against cervical cancer cells by both initiating autophagy and inhibiting lysosomal function.
Feng X; Zhou J; Li J; Hou X; Li L; Chen Y; Fu S; Zhou L; Li C; Lei Y
Cell Death Dis; 2018 Nov; 9(11):1117. PubMed ID: 30389907
[TBL] [Abstract][Full Text] [Related]
29. Apatinib exerts anti-tumour effects on ovarian cancer cells.
Ding J; Cheng XY; Liu S; Ji HY; Lin M; Ma R; Meng FL
Gynecol Oncol; 2019 Apr; 153(1):165-174. PubMed ID: 30651189
[TBL] [Abstract][Full Text] [Related]
30. Apatinib Induces Ferroptosis of Glioma Cells through Modulation of the VEGFR2/Nrf2 Pathway.
Xia L; Gong M; Zou Y; Wang Z; Wu B; Zhang S; Li L; Jin K; Sun C
Oxid Med Cell Longev; 2022; 2022():9925919. PubMed ID: 35602105
[TBL] [Abstract][Full Text] [Related]
31. The poly (ADP-ribose) polymerase inhibitor rucaparib suppresses proliferation and serves as an effective radiosensitizer in cervical cancer.
Tang M; Liu Q; Zhou L; Chen L; Yang X; Yu J; Wang Y; Qiu H
Invest New Drugs; 2019 Feb; 37(1):65-75. PubMed ID: 29872938
[TBL] [Abstract][Full Text] [Related]
32. Synergistic antitumor effect of combined paclitaxel with FEN1 inhibitor in cervical cancer cells.
He L; Yang H; Zhou S; Zhu H; Mao H; Ma Z; Wu T; Kumar AK; Kathera C; Janardhan A; Pan F; Hu Z; Yang Y; Luo L; Guo Z
DNA Repair (Amst); 2018 Mar; 63():1-9. PubMed ID: 29358095
[TBL] [Abstract][Full Text] [Related]
33. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
Sreekanth CN; Bava SV; Sreekumar E; Anto RJ
Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920
[TBL] [Abstract][Full Text] [Related]
34. Stimulator of interferon response cGAMP interactor overcomes ERBB2-mediated apatinib resistance in head and neck squamous cell carcinoma.
Ye G; Zhang J; Zhang C
Aging (Albany NY); 2021 Aug; 13(16):20793-20807. PubMed ID: 34459788
[TBL] [Abstract][Full Text] [Related]
35. Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma.
Liu K; Ren T; Huang Y; Sun K; Bao X; Wang S; Zheng B; Guo W
Cell Death Dis; 2017 Aug; 8(8):e3015. PubMed ID: 28837148
[TBL] [Abstract][Full Text] [Related]
36. Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma.
Liao J; Jin H; Li S; Xu L; Peng Z; Wei G; Long J; Guo Y; Kuang M; Zhou Q; Peng S
J Exp Clin Cancer Res; 2019 Nov; 38(1):454. PubMed ID: 31694662
[TBL] [Abstract][Full Text] [Related]
37. Apatinib-induced protective autophagy and apoptosis through the AKT-mTOR pathway in anaplastic thyroid cancer.
Feng H; Cheng X; Kuang J; Chen L; Yuen S; Shi M; Liang J; Shen B; Jin Z; Yan J; Qiu W
Cell Death Dis; 2018 Oct; 9(10):1030. PubMed ID: 30301881
[TBL] [Abstract][Full Text] [Related]
38. The inhibitory effects of carnosic acid on cervical cancer cells growth by promoting apoptosis via ROS-regulated signaling pathway.
Su K; Wang CF; Zhang Y; Cai YJ; Zhang YY; Zhao Q
Biomed Pharmacother; 2016 Aug; 82():180-91. PubMed ID: 27470354
[TBL] [Abstract][Full Text] [Related]
39. Targeting ERK combined with apatinib may be a promising therapeutic strategy for treating oral squamous cell carcinoma.
Zhao TC; Liang SY; Zhou ZH; Ju WT; Zhang ZY; Zhu DW; Zhong LP
Am J Cancer Res; 2021; 11(6):2960-2974. PubMed ID: 34249438
[TBL] [Abstract][Full Text] [Related]
40. Novel role of apatinib as a multi-target RTK inhibitor in the direct suppression of hepatocellular carcinoma cells.
Li X; Xu A; Li H; Zhang B; Cao B; Huang J
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1693-1701. PubMed ID: 29486282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
